FDA Approves New Drug for Uncontrolled Blood Pressure
Aprocitentan, targeting the endothelin pathway, offers a new approach for managing hypertension alongside existing medications.
Aprocitentan, targeting the endothelin pathway, offers a new approach for managing hypertension alongside existing medications.